News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Phenomenex, Inc. Phree Phospholipid Removal Plates Win R&D 100 Award



7/12/2013 11:36:38 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Torrance, CA (July 12, 2013) - Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, announced today that its Phree Phospholipid Removal Plates have been recognized as one of the top innovations of 2012 by "R&D Magazine." This is the ninth Phenomenex product to receive this award in the last 10 years. The awards, determined by an independent judging panel and the editors of "R&D Magazine," recognize the 100 most technologically significant products introduced during the past year. According to the magazine, the awards are widely regarded as the "Oscars of Innovation." The winners represent a cross-section of industry, academia, private research firms and government labs. Winning technologies are used in medical, industrial, research, consumer and manufacturing applications.

According to Phenomenex president and CEO Fasha Mahjoor, "These awards reflect the depth of our product development pipeline and the fast pace at which we are able to bring new technologies to market."

Phree Phospholipid Removal Plates provide fast cleanup of plasma samples in pharmaceutical and clinical research laboratories. In one step, Phree removes both proteins and phospholipids and delivers the prepared plasma to a collection plate. The high-capacity Phree sorbent can process up to 400 µL per well and remove 99.0 to 100 percent of lysophosphatidyl and phosphatidyl cholines, which are not removed when a simple protein precipitation is performed.

Successful chromatographic analysis of plasma samples requires the removal of both proteins and phospholipids, which can clog HPLC/UHPLC columns. Phospholipids can also cause ion suppression and over time will reduce sensitivity due to buildup on the mass spec source. Phree removes both proteins and phospholipids in one step, eliminating time-consuming method development. The plate format enables the simultaneous processing of 96 samples, for significant time savings.

Winners will be recognized at the R&D 100 Awards Banquet on November 7. A list of winning innovations is on the R&D 100 Awards website, www.rdmag.com.

Phenomenex is a global technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers in industrial, clinical research, government and academic laboratories. From drug discovery and pharmaceutical development to disease diagnosis, food safety and environmental analysis, Phenomenex chromatography solutions accelerate science and help researchers improve global health and well-being. For more information on Phenomenex, visit www.phenomenex.com or follow the company on Twitter @Phenomenex.

Please send READER INQUIRIES from this news release directly to: info@phenomenex.com

Contacts:

Jennifer Dahlgren, Dahlgren Communications

Phone: (530) 263-6817

E-mail: dahlgrenpr@comcast.net

Karen Anspach, Phenomenex, Inc.

Phone: (310) 212-0555, ext. 3243

E-mail: karena@phenomenex.com

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES